Published in Hepatitis Weekly, January 8th, 2001
Rebetol is for separate use in combination with Intron A (interferon alfa-2b, recombinant) Injection for the treatment of chronic hepatitis C in patients with compensated liver disease previously untreated with alpha interferon or who have relapsed following alpha interferon therapy.
Rebetol is approved in the United States for this indication as a component of Rebetron Combination Therapy,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly